News – Page 946 – Endpoints News

Peer Review: Leaving Cerecor after a year, Peter Greenleaf starts a new CEO chapter at Aurinia — out to slay ...

7 years ago

Sonde wants to listen for disease — M Ventures heard the Boston biotech, and led a $16M round to supercharge ...

7 years ago

Still early stage, but this Flagship upstart recruited a Big Pharma exec with a $4.3M compensation package and an IPO ...

7 years ago

Going viral? J&J tries to spark a Twitterstorm for the latest data on its HIV med

7 years ago

FDA tells Sprout Pharma, like it or not the black box on Addyi stays, but we will dilute the warning

7 years ago

A blockbuster cocktail? Gilead slides Novo Nordisk's semaglutide into new NASH triple therapy

7 years ago

Cambrex completes $24M API manufacturing facility; Twist and LakePharma partner on antibody contract work

7 years ago

Two Syncona-backed players join forces to take on retinal gene therapies

7 years ago

Gilead shores up hope for NASH cocktail with a glimpse at positive proof-of-concept data

7 years ago

Bristol-Myers details its failure on Checkmate 451, highlighting a bleak future for their checkpoint combo

7 years ago

Scynexis finds itself in the spotlight with a weapon that may fight a superbug that’s scaring the world to death

7 years ago

Braeburn petitions FDA to revoke Sublocade orphan designation

7 years ago

Regeneron, Alnylam spell out a research alliance that could run beyond a decade, with billions built in for success

7 years ago

Jude Samulski's gene therapy company just raised $235M for clinical development

7 years ago

Faced by R&D setbacks and questionable gains, Gilead’s new CEO’s first move is to reach for the ax

7 years ago

In combat mode, Indivior hunkers down for a war with DoJ over multibillion-dollar fraud charges

7 years ago

FDA, Brigham and Women’s to test if RWE is ripe now for replacing clinical drug trials

7 years ago

Lynparza secures third EU nod; Protein degradation biotech grabs $16M launch round from Chinese VCs; Wave shares ...

7 years ago

Inozyme brings $67M to the bank to build up its calcification-focused rare disease pipeline

7 years ago

Chinese player joins a growing group of biotechs buying into Synaffix's ADC linker tech

7 years ago

Compared to avoidance, Aimmune's peanut allergy treatment an improvement over DBV's product — ICER

7 years ago

Gene therapies for the cats and dogs you love? Penn-partnered Scout Bio just raised $20M to make it a reality

7 years ago

As public furor mounts, Sanofi makes deep cuts to US insulin prices in savings program

7 years ago

Once spurned, Amgen wins the FDA over with its bone-building osteoporosis drug Evenity

7 years ago

First page Previous page 943 944 945946947 948 949 Next page Last page